RAD News Alert Rite Aid Corp (RAD) 8.34 02/13/2015 22:36:10

New Post Public Reply Private Reply Replies (0) Message Board

Feb 13, 2015 at 11:36 PM

Rite Aid Corp (RAD) 8.34 $RAD

U.S. Northeast braces for another major winter storm
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 12:51PM CST

DNKN: 46.70 (-0.69), FIVE: 33.01 (+0.11), RAD: 8.34 (+0.25)

Rite Aid (RAD) Jumps 6.6% on TPG's EnvisionRx Buyout - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 10:40AM CST
Rite Aid (RAD) announced that it has penned a deal with EnvisionRx, to buy the latter for roughly $2 billion.
ESRX: 84.90 (+0.40), WBA: 78.73 (-1.23), CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)

Retail sales: What to like
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 8:43AM CST

DFRG: 19.14 (-0.03), PNRA: 155.02 (-2.31), CAB: 53.55 (+1.23), LL: 63.69 (+0.89), EAT: 59.16 (-0.18), JACK: 87.12 (-1.00), CAKE: 48.22 (-1.04), COSI: 2.80 (unch), PZZA: 62.11 (-1.11), LOCO: 24.20 (+0.06), LOW: 72.05 (-0.14), KKD: 21.06 (-0.28), YUM: 74.69 (-0.11), BGFV: 12.53 (+0.17), FRS: 27.79 (+0.29), DKS: 53.95 (+0.47), HABT: 30.87 (+0.10), RAD: 8.34 (+0.25), ZOES: 31.34 (+0.22), QSR: 38.74 (-0.58), WBA: 78.73 (-1.23), CBRL: 130.79 (-0.16), FRSH: 13.25 (-0.05), CVS: 102.63 (-0.37), ULTA: 136.66 (+0.59), BBRG: 13.49 (-0.01), BLMN: 24.45 (-0.16), WEN: 10.95 (-0.15), HIBB: 49.60 (+0.20), SBH: 33.10 (+0.28), BOBE: 56.41 (-0.68), BWLD: 187.27 (+0.30), SBUX: 91.58 (-0.24), NATH: 77.03 (-0.34), SONC: 31.59 (-0.37), IRG: 6.95 (-0.02), GTIM: 8.23 (+0.07), CMG: 674.89 (+4.60), DPZ: 100.00 (-0.56), PBPB: 13.92 (-0.07), SPWH: 7.22 (+0.01), TAST: 7.93 (+0.03), TXRH: 34.59 (+0.07), BDL: 34.03 (-0.42), RUTH: 15.73 (+0.88), HD: 111.89 (-0.27), RRGB: 77.77 (-0.20), CHUY: 22.04 (-0.35), PLKI: 61.07 (+0.44), DIN: 104.49 (-0.51), FRGI: 61.80 (-0.33), DENN: 10.68 (+0.03), DRI: 61.72 (+0.31), RT: 6.40 (+0.20), LUB: 5.03 (-0.03), NDLS: 25.96 (+0.23)

Rite Aid (RAD) Worth Watching: Stock Moves 6.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:25AM CST
Rite Aid (RAD) was a big mover last session, with shares rising roughly 7% on the day.
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)

Greece Issue Is Blown Out Of Proportion - Cramer's Mad Money (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 6:44AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, February 11. It is the overseas issue again. Cramer thinks the critics have come back to cause investor fear on the Germany-Greece showdown. Cramer called it...
PBR.A: 7.13 (+0.48), SDRL: 12.32 (-0.70), GOOG: 549.01 (+6.08), SLB: 88.38 (+2.42), PEP: 99.13 (-1.14), RAD: 8.34 (+0.25), ZTS: 45.46 (-0.33), JNJ: 99.62 (+1.18), CMG: 674.89 (+4.60), DNB: 133.27 (+0.46), AAL: 48.39 (+0.51), GM: 37.62 (-0.40), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), DOW: 49.44 (+0.29), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), CSCO: 29.43 (-0.03)

Rite Aid to acquire Envision Pharmaceutical Services for USD2bn
M2 - Thu Feb 12, 4:46AM CST
Drug store Rite Aid (NYSE:RAD) reported on Wednesday the execution of an agreement to acquire Envision Pharmaceutical Services (EnvisionRx) in a transaction valued at approximately USD2bn, which includes the value of an expected future tax benefit of USD275m.
RAD: 8.34 (+0.25)

Rite Aid Investors Should Wait On Shares
Dallas Salazar - at Seeking Alpha - Thu Feb 12, 2:11AM CST

RAD: 8.34 (+0.25)

Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)

Rite Aid Shares Up 42.5% Since SmarTrend's Buy Recommendation (RAD)
Comtex SmarTrend(R) - Wed Feb 11, 4:47PM CST
SmarTrend identified an Uptrend for Rite Aid (NYSE:RAD) on December 8th, 2014 at $5.67. In approximately 2 months, Rite Aid has returned 42.50% as of today's recent price of $8.08.
RAD: 8.34 (+0.25)

Stock Markets Close Flat Amid Uncertainty About Greece
at The Street - Wed Feb 11, 4:13PM CST
Stocks end the day little-changed as U.S. investors await more information on a debt deal between the eurozone and Greece.
WFM: 56.15 (-0.15), HAL: 44.19 (+1.42), TRIP: 84.81 (+2.41), WMT: 85.81 (-0.08), SHLD: 35.70 (+2.32), RAD: 8.34 (+0.25), FSLR: 48.84 (-0.58), TGT: 76.12 (-0.75), AAPL: 127.08 (+0.62), CSCO: 29.43 (-0.03), BHI: 64.31 (+1.93)

Jim Cramer Explains Why Rite Aid (RAD) is Now a Growth Stock After Envision Acquisition
at The Street - Wed Feb 11, 3:22PM CST
TheStreet's Jim Cramer explains why he likes Rite Aid's (RAD) $2 billion acquisition of pharmacy benefit manager Envision Pharmaceutical Services.
CVS: 102.63 (-0.37), WAG: 76.05 (-0.49), RAD: 8.34 (+0.25)

Stocks End Mixed: Molina Healthcare Rises Again
at Investor's Business Daily - Wed Feb 11, 3:22PM CST
Stocks ended mixed Wednesday as investors fretted about talks between Greek and European finance ministers about a debt compromise. The Nasdaq edged up 0.3%, while the S&P 500 and the Dow Jones industrial average each dipped a fraction. Volume was...
BIIB: 391.66 (-0.45), MOH: 59.66 (+0.26), CELG: 115.88 (+0.16), RAD: 8.34 (+0.25)

Stocks Briefly Spike as Obama Sets Out Plan of Action for ISIS
at The Street - Wed Feb 11, 2:39PM CST
Stocks slide as U.S. investors await some information on a debt deal between the eurozone and Greece.
FSLR: 48.84 (-0.58), AOL: 41.78 (+1.22), TGT: 76.12 (-0.75), HAL: 44.19 (+1.42), WMT: 85.81 (-0.08), SHLD: 35.70 (+2.32), AAPL: 127.08 (+0.62), RAD: 8.34 (+0.25), BHI: 64.31 (+1.93)

How to Trade the Market's Most-Active Stocks: Apple, Pier 1 and More
at The Street - Wed Feb 11, 1:34PM CST
Here's a technical look at how to trade some of the most active stocks on the market today.
PIR: 12.52 (+0.17), SDRL: 12.32 (-0.70), AAPL: 127.08 (+0.62), RAD: 8.34 (+0.25)

6 Ways Rite Aid's Acquisition Of EnvisionRx Will Take Its Stock Higher
Brian Nichols - at Seeking Alpha - Wed Feb 11, 11:15AM CST

GILD: 101.90 (+1.10), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00), RAD: 8.34 (+0.25)

Stocks Mixed as Wall Street Watches Greek Debt Talks Play Out
at The Street - Wed Feb 11, 10:15AM CST
Stocks are mixed on Wednesday with Wall Street's well of optimism over a Greek debt deal, which boosted the S&P 500 by 1% on Tuesday, tapping out.
HAL: 44.19 (+1.42), WMT: 85.81 (-0.08), SHLD: 35.70 (+2.32), PEP: 99.13 (-1.14), RAD: 8.34 (+0.25), FSLR: 48.84 (-0.58), AOL: 41.78 (+1.22), ARMH: 49.92 (-0.49), TGT: 76.12 (-0.75), AAPL: 127.08 (+0.62), BHI: 64.31 (+1.93)

Rite Aid Sees Wider Margins in $2 Billion Envision Deal
at The Street - Wed Feb 11, 10:03AM CST
The cash-and-stock acquisition of the TPG Capital-backed pharmacy-benefit manager follows rival CVS' successful purchase of Caremark.
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)

Today's Market: Earnings And Acquisitions Pushing These Names Higher
Matthew Smith - at Seeking Alpha - Wed Feb 11, 9:39AM CST

NFLX: 466.10 (+9.37), KO: 41.99 (-0.18), TSLA: 203.77 (+0.89), PIR: 12.52 (+0.17), LGF: 32.17 (+0.08), CVS: 102.63 (-0.37), STRZB: 30.37 (+1.95), TWX: 83.87 (+0.56), STRZA: 31.75 (-0.25), RAD: 8.34 (+0.25), PEP: 99.13 (-1.14)

Cramer: Rite Aid Continues to Impress, Shares Will Hit New Highs
at The Street - Wed Feb 11, 9:38AM CST
Jim Cramer applauds Rite Aid's management, saying the company is no longer in turnaround mode. The $2 billion acquisition of Envision will help to fuel its growth.
CVS: 102.63 (-0.37), RAD: 8.34 (+0.25)

Stocks Open Mixed, Techs Climb; Rite Aid, Akamai, AmTrust Jump
at Investor's Business Daily - Wed Feb 11, 9:36AM CST
Stocks opened in a tightly mixed formation Wednesday, as tech stocks pulled higher and the energy sector once again turned south. The Nasdaq climbed 0.2% with a strong mix of Nasdaq 100 stocks pulling higher. The Dow Jones industrial average fell...
KO: 41.99 (-0.18), TSLA: 203.77 (+0.89), BIIB: 391.66 (-0.45), BIDU: 212.13 (+7.11), PNRA: 155.02 (-2.31), AKAM: 68.77 (+1.18), AFSI: 55.60 (-0.89), CAT: 85.13 (+1.60), CSCO: 29.43 (-0.03), RAD: 8.34 (+0.25)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ford Foundation Welcomes Gender Justice Leader Fatima Goss Graves

A Fresh Addition to Ford's Trustees Fatima Goss Graves steps into big shoes at the Ford Foundation as she gets appointed to its Board of Trustees. No small potatoes, this move suggests the Foundation's commitment to driving significant gender justice and advocacy. Add her name next to serious change-makers, folks, because Ms. Goss Graves is a heavyweight in the nonprofit...

Coastal Financial Faces Lawsuit Over Fraud Allegations

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Moore Law Urges Millrose Investors: Join the Action

Is Millrose Playing a Risky Game? When I caught wind of this latest debacle with Millrose Properties, Inc. (NYSE: MRP), my gut reaction was a mix of curiosity and skepticism. Hunterbrook Media's report just blasted across the headlines, digging up some dirt on Millrose's recent financial maneuvers. Apparently, these cats have been busy buying homes to the tune of $200...

Ruth E. Carter Returns Home with Celebrated Exhibition

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

PrePass Intelligence: A Game-Changer for Fleets

Picture this: you're at the wheel of a beastly 18-wheeler, barreling down the highway and skipping weigh stations thanks to PrePass. But here’s where the real magic kicks in. PrePass Intelligence just rolled out, aiming to squeeze every last drop of value from bypass and toll data. That's cold hard cash for fleet operators who can finally make sense of these fleeting...

Ball Corp's Leadership Shuffle Aims for Strategic Gains

Leadership Changes in the Midst of Market Challenges You don't need a crystal ball to see that leadership changes can signal either turmoil or opportunity. Ball Corporation, a titan in the realm of aluminum packaging, is experiencing a shake-up at the top of its beverage packaging business units. With Carey Causey stepping into the role for North and Central America, and...

Art Print Paper: Finding the Perfect Match for Masterpieces

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

QFIN Faces Class Action: Investors' Role Explored

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Spooky Suds: House of Horror Meets El Car Wash

A Haunted Wash Awaits Miami Drivers Picture this: you're cruising down West Flagler on a regular Wednesday evening, but tonight, you're not just rolling in for a rinse. Nope, this Wednesday night, the wash tunnel at El Car Wash gets downright spooky. It's getting a haunted house makeover with scare actors from the House of Horror. When a Car Wash Becomes a Haunted...

OppFi Readies Q3 Earnings; Investors Eye Financials

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...